4/10
08:06 am
IONS
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
4/10
08:06 am
IONS
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
4/10
04:30 am
IONS
Rating for IONS
Low
Report
Rating for IONS
4/10
04:30 am
IONS
Rating for IONS
Low
Report
Rating for IONS
4/9
05:38 pm
IONS
Ionis Pharmaceuticals upgraded to Outperform at Wolfe Research
Low
Report
Ionis Pharmaceuticals upgraded to Outperform at Wolfe Research
4/9
05:38 pm
IONS
Ionis Pharmaceuticals upgraded to Outperform at Wolfe Research
Low
Report
Ionis Pharmaceuticals upgraded to Outperform at Wolfe Research
4/9
04:39 pm
IONS
Ionis upgraded to Outperform from Peer Perform at Wolfe Research
Low
Report
Ionis upgraded to Outperform from Peer Perform at Wolfe Research
4/9
04:39 pm
IONS
Ionis upgraded to Outperform from Peer Perform at Wolfe Research
Low
Report
Ionis upgraded to Outperform from Peer Perform at Wolfe Research
4/9
11:17 am
IONS
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at William Blair.
4/9
11:17 am
IONS
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at William Blair.
4/9
08:26 am
IONS
Rating for IONS
Low
Report
Rating for IONS
4/9
08:26 am
IONS
Rating for IONS
Low
Report
Rating for IONS
4/9
08:09 am
IONS
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
4/9
06:33 am
IONS
Rating for IONS
Low
Report
Rating for IONS
4/9
06:33 am
IONS
Rating for IONS
Low
Report
Rating for IONS
3/6
08:56 am
IONS
Rating for IONS
Low
Report
Rating for IONS
3/6
08:56 am
IONS
Rating for IONS
Low
Report
Rating for IONS
2/26
09:06 am
IONS
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $65.00 price target on the stock, up previously from $63.00.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $65.00 price target on the stock, up previously from $63.00.
2/26
08:38 am
IONS
Rating for IONS
Low
Report
Rating for IONS
2/26
08:38 am
IONS
Rating for IONS
Low
Report
Rating for IONS
2/22
08:07 am
IONS
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
2/22
05:10 am
IONS
Rating for IONS
Low
Report
Rating for IONS
2/22
05:10 am
IONS
Rating for IONS
Low
Report
Rating for IONS
2/14
04:17 pm
IONS
Ionis Pharmaceuticals initiated with neutral view at Wolfe Research
Medium
Report
Ionis Pharmaceuticals initiated with neutral view at Wolfe Research
2/14
04:17 pm
IONS
Ionis Pharmaceuticals initiated with neutral view at Wolfe Research
Medium
Report
Ionis Pharmaceuticals initiated with neutral view at Wolfe Research